Imexpharm Corp (IMP) — Cash Flow Quality Index
Imexpharm Corp (IMP) has a Cash Flow Quality Index of 1.26x as of March 2026. Operating cash flow of ₫103.49 Billion exceeds net income of ₫82.02 Billion, indicating high earnings quality where cash backs reported profits. Also explore Imexpharm Corp balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Imexpharm Corp Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Imexpharm Corp across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Imexpharm Corp tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Imexpharm Corp (2019–2025)
Year-by-year earnings quality comparison for Imexpharm Corp. For live market cap and the full company financial profile, see how much is Imexpharm Corp worth.
| Year | Quality Index | Operating CF (VND) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | ₫54.17 Billion | ₫349.14 Billion | ▼ -77.0% |
| 2024 | 0.67x | ₫216.27 Billion | ₫320.86 Billion | ▲ +598.9% |
| 2023 | -0.14x | ₫-40.47 Billion | ₫299.56 Billion | ▼ -108.3% |
| 2022 | 1.62x | ₫378.60 Billion | ₫233.96 Billion | ▲ +30.3% |
| 2021 | 1.24x | ₫234.88 Billion | ₫189.09 Billion | ▲ +256.1% |
| 2020 | 0.35x | ₫73.15 Billion | ₫209.70 Billion | ▼ -14.9% |
| 2019 | 0.41x | ₫66.59 Billion | ₫162.39 Billion | — |